The proportion of ownership interest in an associate attributable to the entity. [Refer: Associates [member]]

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2021-01-01
-Paragraph 17
-Subparagraph b
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard
-URIDate 2021-03-24

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Name IAS
-Number 27
-IssueDate 2021-01-01
-Paragraph 16
-Subparagraph b
-Clause iii
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard
-URIDate 2021-03-24

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 12
-IssueDate 2021-01-01
-Paragraph 21
-Subparagraph a
-Clause iv
-URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_21_a_iv&doctype=Standard
-URIDate 2021-03-24

Name:	ifrs-full_ProportionOfOwnershipInterestInAssociate
Namespace Prefix:	ifrs-full_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Related Parties - Additional Information (Details) € in Thousands	12 Months Ended
	Dec. 31, 2021 Co-founder employee	Dec. 31, 2020 EUR (€)
Biotech Avenir SAS
Disclosure of transactions between related parties [line items]
Number of co-founders hold share capital of related party \| Co-founder	4
Number of employees hold share capital of related party \| employee	12
Biotech Avenir SAS \| Genfit
Disclosure of transactions between related parties [line items]
Proportion of ownership interest in associate (as a percent)	3.79%
The NASH Epidemiology Institute TM
Disclosure of transactions between related parties [line items]
Endowment fund balance		€ 17
Associates [member] \| PCAS Group
Disclosure of transactions between related parties [line items]
Technology transfers cost		€ 255